Streetbeat News

MNDR

Mobile health Network Solutions

Open

0.40

Mkt cap

13M

Volume

117K

High

0.40

P/E Ratio

-0.70

52-wk high

29.50

Low

0.39

Div yield

N/A

52-wk low

0.39

Several healthcare stocks experienced significant price movements in Monday's pre-market session. Notable gainers include Healthcare Triangle, Evoke Pharma, and Monte Rosa Therapeutics, while Koninklijke Philips and Monopar Therapeutics were among the losers.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 12:07 pm

Several healthcare stocks experienced significant movements in Monday's pre-market session. Notable gainers include Evoke Pharma, Healthcare Triangle, and Monte Rosa Therapeutics, while Koninklijke Philips and Monopar Therapeutics were among the losers.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 12:07 pm

Tesla shares surged by 10.8% in pre-market trading after reporting better-than-expected Q3 earnings. Several other stocks also showed significant pre-market movements, including CCSC Technology, Mobile-health Network Solutions, and CNS Pharmaceuticals among gainers, while SaverOne 2014 and Gold Resource Corporation were among the losers.

Portfolio Pulse from Avi Kapoor

October 24, 2024 | 10:21 am

Mobile-health Network Solutions reported a fiscal year 2024 EPS of $(0.56) and revenue of $14 million.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:59 pm

Mobile-health Network Solutions reported a correction in their FY24 revenue, which increased by $6.1 million to a total of $14 million.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:58 pm

Mobile-health Network Solutions reported a 77% year-over-year increase in FY24 revenue, reaching $6.1 million.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:46 pm

Mobile-Health Network Solutions shares are trading higher following the release of their FY24 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 8:44 pm

Several health care stocks experienced significant price movements in Monday's pre-market session. GRI Bio, BioVie, LogicMark, VSee Health, Molecular Partners, and Windtree Therapeutics saw notable gains, while Gritstone Bio, Mobile-health Network, LifeStance Health, Akanda, Phio Pharma, and Burning Rock Biotech experienced declines.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 12:08 pm

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 12:07 pm

MaNaDr, a telehealth provider, received a Nasdaq notice for not meeting the minimum bid price rule, with a deadline until March 2025 to comply. The company must raise its share price above $1.00 for 10 consecutive days to avoid delisting.

Portfolio Pulse from Benzinga Newsdesk

September 23, 2024 | 7:08 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.